Groupama Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.92M | Sell |
35,433
-12,492
| -26% | -$1.38M | 0.06% | 128 |
|
|
2025
Q1 | $5.36M | Sell |
47,925
-6,247
| -12% | -$698K | 0.11% | 99 |
|
|
2024
Q4 | $4.98M | Sell |
54,172
-5,871
| -10% | -$540K | 0.1% | 114 |
|
|
2024
Q3 | $4.04M | Buy |
60,043
+24,956
| +71% | +$1.68M | 0.11% | 118 |
|
|
2024
Q2 | $2.41M | Sell |
35,087
-4,788
| -12% | -$329K | 0.03% | 189 |
|
|
2024
Q1 | $4.48M | Sell |
39,875
-22,381
| -36% | -$2.52M | 0.08% | 145 |
|
|
2023
Q4 | $5.04M | Buy |
+62,256
| New | +$5.04M | 0.13% | 113 |
|